MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, ORKA has $509,251K in assets. $22,460K in debts. $91,253K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
1693.91%
Cash Ratio
435.22%
Debt to Asset Ratio
4.41%
Assets Breakdown
    • Marketable securities, current
    • Marketable securities, long-term
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Related party common stock warra...
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
91,253 65,396
Marketable securities, current
257,902 263,010
Prepaid expenses and other current assets
6,008 3,606
Total current assets
355,163 332,012
Marketable securities, long-term
151,763 23,053
Property and equipment, net
253 174
Operating lease right-of-use assets
1,969 2,076
Other non-current assets
103 103
Total assets
509,251 357,418
Accounts payable
2,208 4,664
Accrued expenses and other current liabilities
8,648 3,578
Operating lease liability, current
419 660
Related party common stock warrant liability-Related Party
9,684 3,089
Related party accounts payable and other current liabilities-Related Party
8 119
Total current liabilities
20,967 12,110
Operating lease liability, non-current
1,493 1,666
Total liabilities
22,460 13,776
Series b non-voting convertible preferred stock, 0.001 par value 251,504 shares authorized as of september 30, 2025 and december 31, 2024 137,138 shares issued and outstanding as of september 30, 2025 and december 31, 2024-Series BNon Voting Convertible Preferred Stock Amount
2,931 2,931
Common stock, 0.001 par value 545,000,000 shares authorized as of september 30, 2025 and december 31, 2024 48,384,150 and 37,440,510 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively
48 37
Additional paid-in capital
643,201 469,998
Accumulated other comprehensive income (loss)
185 -27
Accumulated deficit
-159,574 -129,297
Total stockholders equity
486,791 343,642
Total liabilities and stockholders equity
509,251 357,418
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Prepaid expenses andother current assets$6,008K Marketable securities,current$257,902K Cash and cashequivalents$91,253K Other non-currentassets$103K Operating leaseright-of-use assets$1,969K Property and equipment,net$253K Marketable securities,long-term$151,763K Total current assets$355,163K Total assets$509,251K Total liabilities andstockholders equity$509,251K Total stockholdersequity$486,791K Total liabilities$22,460K Accumulated deficit-$159,574K Accumulated othercomprehensive income (loss)$185K Additional paid-in capital$643,201K Operating leaseliability, non-current$1,493K Total currentliabilities$20,967K Common stock, 0.001 parvalue 545,000,000...$48K Series b non-votingconvertible preferred...$2,931K Related party accountspayable and other...$8K Related party commonstock warrant...$9,684K Operating leaseliability, current$419K Accrued expenses andother current...$8,648K Accounts payable$2,208K

Oruka Therapeutics, Inc. (ORKA)

Oruka Therapeutics, Inc. (ORKA)